The Intersurgical i-flo™ nasal cannula is a single use patient interface intended for the delivery of High Flow Oxygen Therapy (HFOT). It is intended to treat adult patients with hypoxemic respiratory failure and intended for use in a hospital environment and is available in three sizes.
HFOT has become a key mode of respiratory support in patients with hypoxemic respiratory failure and is considered to offer a number of benefits versus more conventional oxygen therapies. These benefits have been shown to include:
• improved oxygenation
• reduced work of breathing
• improved secretion clearance
• improved patient tolerance
• avoidance of intubation1
The i-flo™ cannula complements Intersurgical’s extensive range of Critical Care breathing systems and interfaces and the unobtrusive design has been developed with a focus on performance and patient comfort. The i-flo™ includes a number of unique features and benefits to help ensure the optimal delivery of high flow oxygen therapy.
Release Information: i-flo high flow nasal cannula is available in selected markets, please consult your local office for further details.
Content from video platforms and social media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.
Intersurgical i-flo™ high flow nasal cannula information sheet (Issue 1)
Intersurgical's i-flo™ high flow nasal cannula
